Company / Capital Returned to Shareholders
Steris Capital Returned to Shareholders History
FY2018-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$212.4M
FY2026
5-year range
$174.3M / $492.1M
FY2022-FY2026
Trend
-56.8%
vs FY2025
Sector context
#51 of 108
Health Care
What the data says
At $212M, Steris's capital returned to shareholders ranks #51 of 108 in the Health Care sector. Capital Returned to Shareholders has fluctuated over the past 9 years, ranging from $148M in FY2020 to $492M in FY2025.
Based on SEC 10-K filings.
$212M in FY2026 with a 5-year CAGR of +1.8%.
Declined from $431M to $212M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +1.8%
- 10-Year CAGR
- -
Sector benchmark
#51 of 108 in Health CareTop 47% of 108This company $212.4M Sector average $754.9M
▼
-71.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.8%, indicating consistent growth.
- In FY2026, capital returned to shareholders decreased 56.8% year-over-year.
- Ranks #51 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2025.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $212.4M | -56.8% |
| FY2025 | $492.1M | +14.1% |
| FY2024 | $431.2M | +103.1% |
| FY2023 | $212.3M | +21.8% |
| FY2022 | $174.3M | -10.2% |
| FY2021 | $194.0M | +30.7% |
| FY2020 | $148.5M | -22.1% |
| FY2019 | $190.7M | -1.7% |
| FY2018 | $194.0M | - |
| FY2017 | - | - |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026